| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3901594 | Urology | 2010 | 7 Pages |
Abstract
Intratumoral changes in computed tomography enhancement after receptor tyrosine kinase inhibition correlate with primary tumor response, and may be a useful adjunct to the standard response evaluation criteria in solid tumors (RECIST criteria) in assessing response to therapy. Prospective studies evaluating antiangiogenic agents should explore intratumoral changes in contrast enhancement as part of response criteria, and examine the effect of intratumoral changes on survival-based outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
C. Lance Cowey, Julia R. Fielding, W. Kimryn Rathmell,